Effect of Boswellia Sacra Versus Calcium Hydroxide as an Intracanal Medicament on Postoperative Pain Intensity and Bacterial Load Reduction in Necrotic Mandibular Premolars: A Randomized Clinical Trial
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This research will study the effect of Boswellia Sacra versus calcium hydroxide as an intracanal medicament on postoperative pain intensity measured using numerical rating scale (NRS) and bacterial load reduction reduction determined by bacterial counting using agar culture technique after root canal preparation (CFU/ml) in mandibular premolars with necrotic pulp.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 45
Healthy Volunteers: t
View:
• Age between 25-45 years old.
• Males or females.
• Healthy patients whom are categorized as I or II according to The American Society of Anesthesiologists. (ASA I or II)
• Patients' accepting to participate in the trial.
• Patients who can understand pain scale and can sign the informed consent.
• Mandibular Single rooted premolars, having single root canal:
‣ Diagnosed clinically with pulp necrosis.
⁃ Absence of spontaneous pulpal pain.
⁃ Positive pain on percussion denoting apical periodontitis.
⁃ Periapical radiolucency not exceeding 2\*2 mm radiographically.
⁃ Normal occlusal contact with opposing teeth.
Locations
Other Locations
Egypt
Cairo University Hospital ,Endodontic clinic
RECRUITING
Giza
Contact Information
Primary
Aya H. Abo Kashwa, Masters
aya.abokashwa@dentistry.cu.edu.eg
01021547230
Backup
Radwa S. Emara, PhD
radwa.emara@dentistry.cu.edu.eg
01272141312
Time Frame
Start Date:2024-05
Estimated Completion Date:2024-08
Participants
Target number of participants:45
Treatments
Experimental: Patients with necrotic mandibular premolars will be treated with boswellia sacra
25-45 years old patients with necrotic single rooted mandibular premolar with single canal with periapical lesion will be treated with boswellia sacra as an intracanal medicament for 3 days
Experimental: Patient with necrotic mandibular premolar will be treated with boswellia sacra
25-45 years old patients with necrotic single rooted mandibular premolar with single canal with periapical lesion will be treated with boswellia sacra as an intracanal medicament for 7 days
Active_comparator: Patients with necrotic mandibular premolar will be treated with calcium hydroxide
25-45 years old patients with necrotic single rooted mandibular premolar with single canal with periapical lesion will be treated with calcium hydroxide as an intracanal medicament for 7 days